Search Results 1001-1010 of 16078 for pharmacogenetics
This research takes a dual perspective (patients and physicians) to examine social media use by chronic disease patients who share their narratives of illness ...
Doctors and scientists in the Hematologic Malignancies Program of the Mayo Clinic Comprehensive Cancer Center are working on improving the diagnosis and ...
The purpose of this study is to compare IgG4-related disease remission and relapse rates between patients who had induction rituximab treatment with or without ...
D., has been mainly focused on autonomic disorders, specifically pure autonomic failure, autoimmune autonomic neuropathies, postural tachycardia syndrome and ...
Faculty members in the Department of Biochemistry and Molecular Biology developing new genetic, proteomic and biomathematics methods to drive research in ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both arms will continue treatment until ...
Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.
About this study. The objectives of this study are to perform genomic testing and trio analysis on specimens from three deceased patients with partial OTC ...
Led by Dr. Sharp, faculty and staff in the Biomedical Ethics Research Program at Mayo Clinic study ethical issues in medicine & biomedical science.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.